BioCentury
ARTICLE | Clinical News

MVA-Muc1-IL2 vaccine: Phase II

May 19, 2003 7:00 AM UTC

In an ongoing European Phase II trial of MVA-Muc1-IL2 as a single agent or in combination with vinorelbine/cisplatin chemotherapy in 66 patients with stage IV NSCLC, an interim analysis in 18 patients...